前の章|次の章

人工知能による仮想細胞の構築：がん研究の展望

  • role： First author第一作者
  • Affiliation：

    Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

    State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

Tao Yang12,  
  • Affiliation：

    Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

    State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

Yuan-Yi Wang12,  
  • role： Corresponding author通信作者
  • Affiliation：

    Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

    State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

  • Email：drmafei@126.com
  • Introduction：* Fei Ma drmafei@126.com
Fei Ma12*,  
  • role： Corresponding author通信作者
  • Affiliation：

    National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

  • Email：xubinghebm@163.com
  • Introduction：Bing-He Xu xubinghebm@163.com
Bing-He Xu3*,  
  • role： Corresponding author通信作者
  • Affiliation：

    State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

  • Email：qianhaili001@163.com
  • Introduction：Hai-Li Qian qianhaili001@163.com
Hai-Li Qian2*

サマリー

キーワード

仮想細胞; 人工知能; がん研究; マルチオミクス

References

  1. 1..
    Bunne C,Roohani Y,Rosen Y,Gupta A,Zhang X,Roed M, et al. How to build the virtual cell with artificial intelligence: priorities and opportuni-ties. Cell. 2024;187(25):7045-63.
  2. 2..
    Yang T,Ma F,Qian H,Xu B. AI-driven construction of digital cell model.Innov Life. 2024;2(4):100102.
  3. 3..
    Karr JR,Sanghvi JC,Macklin DN,Gutschow MV,Jacobs JM,JrBolival B, et al. A whole-cell computational model predicts phenotype from geno-type. Cell. 2012;150(2):389-401.
  4. 4..
    Maritan M,Autin L,Karr J,Covert MW,Olson AJ,Goodsell DS. Building structural models of a whole mycoplasma cell. J Mol Biol.2022;434(2):167351.
  5. 5..
    Turner NC,Im SA,Saura C,Juric D,Loibl S,Kalinsky K, et al. Inavolisib-based therapy in PIK3CA-mutated advanced breast cancer. N Engl J Med.2024;391(17):1584-96.
  6. 6..
    Zitnik M,Li MM,Wells A,Glass K,Morselli Gysi D,Krishnan A, et al.Current and future directions in network biology. Bioinform Adv.2024;4(1):vbae099.
  7. 7..
    Katsoulakis E,Wang Q,Wu H,Shahriyari L,Fletcher R,Liu J, et al. Digital twins for health: a scoping review. NPJ Digit Med. 2024;7(1):77.
  8. 8..
    Moding EJ,Nabet BY,Alizadeh AA,Diehn M. Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease. Cancer Discov. 2021;11(12):2968-86.
  9. 9..
    Zhang YP,Zhang XY,Cheng YT,Li B,Teng XZ,Zhang J, et al. Artificial intelligence-driven radiomics study in cancer: the role of feature engi-neering and modeling. Mil Med Res. 2023;10(1):22.
  10. 10..
    Liu J,Shen Z,He Y,Zhang X,Xu R,Yu H, et al. Towards out-of-distribution generalization: a survey. arXiv, 2021:2108.13624.

続きを読む

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website